“INTERFERON (ROFERON-A)”
OLEH:
1. IDA AYU HELSHE GIANA PUTRI KUMARA (161200062/A1C)
2. LUH GEDE ADELIA SURYANINGSIH (161200063/A1C)
3. NI KETUT KUSUMA WARDANI (161200064/A1C)
4. NI KETUT SRI MULYATI ANTARI (161200065/A1C)
5. NI KOMANG SUKMA GITA SARI (161200066/A1C)
6. NI MADE AYU CANDRA DEWI (161200067/A1C)
7. NI MADE AYU UTAMI (161200068/A1C)
PENDAHULUAN
Selain itu terdapat juga proses down stream bioteknologi inteferon (IFNs)
yang meliputi pemisahan protein dengan sel, proses pemurnian protein.
modifikasi protein atau manipulasi DNA dengan menggunakan berbagai enzim.
Proses pemisahan protein dengan sel yaitu menggunakan Western blotting, protein
dipisahkan berdasarkan ukuran massanya dengan cara elektroforesis gel
poliakrilamida, Proses pemurnian protein yang umumnya dilakukan yaitu dengan
penambahan larutan fenol ataupun dengan campuran fenol kloroform dengan
perbandingan 1:1, untuk mengendapkan protein dengan cara disentrifus dan
dihancurkan secara enzimatis dengan proteinase, dan terakhir proses Manipulasi
DNA dapat dilakukan secara enzimatis dengan menggunakan berbagai macan
enzim diantaranya yaitu Enzim Endonuklease, Enzim DNA Ligase, Enzim DNA
Polimerase.
4.2 Saran
Demikian yang dapat kami paparkan mengenai materi yang menjadi pokok
bahasan dalam makalah ini, tentunya masih banyak kekurangan dan
kelemahannya, karena terbatasnya pengetahuan dan kurangnya rujukan atau
refrensi yang ada hubungannya dengan judul tugas ini.
Ruther, U., Nunnensiek, C., Muller, H.A., Bader, H., May, U., & Jipp, P. (1998).
Interferon alpha (IFN alpha 2a) therapy for herpes virus-
associated inflammatory bowel disease (ulcerative colitis and
Crohn's disease). Hepatogastroenterology, 45(21), 691-699.
Wang, Y, Cen, Y., & Li, Z. (2007). Therapeutic result of operation combined with
large-dose of roferon-A for cutaneous malignant melanoma.
Zhongguo xiu fu chong jian wai ke za zhi =Zhongguo xiufu
chongjian waike zazhi = Chinese journal of reparative and
reconstructive surgery, 21(1), 37.
Roy, S., Patil, D., Ghadigaonkar, S., Roy, R., Mukherjee, S., Chowdary, A., &
Deshmukh, R. (2015). A preliminary study of recombinant
human interferon-α-2a activity against rabies virus in murine
model. Indian Journal of Medical Microbiology, 33(1), 132-135.
doi:10.4103/0255-0857.148412.
Golan, D. E., Baca, Q. J., & Leader, B. (2008). Protein therapeutics: a summary
and pharmacological classification. Nature Reviews Drug
Discovery, 7, 21-39.
Xu, K., Lee, F., Gao, S. J., Chung, J. E., Yano, H., & Kurisawa, M. (2013).
Injectable hyaluronic acid-tyramine hydrogels incorporating
interferon-α2a for liver cancer therapy. Journal of controlled
release : official journal of the Controlled Release Society,
166(3), 203-210. doi: 10.1016/ j.jconrel.2013.01.008.
Kusmwati, A. 2013. Kloning Gen Human Interferon Alpha 2a Pada Vektor pET-
32b(+) dan Ekspresi Pada Escherichia coli (Tesis). Fakultas
Farmasi. Universitas Indonesia.
Fuh G., Mulkerrin M. G., Bass S., McFarland N., Brochier M., Bourell J. H.,
Light D. R., and Wells J. A. (1990). The human growth hormone
receptor. Secretion from Escherichia coli and disulfide bonding pattern of
the extracellular binding domain. J. Biol. Chem., 265, 3111-31153.
Grompe M., Johnson W., and Jameson L. (1998). Recombinant DNA and genetic
techniques. In Principles of molecular medicine. Edited by J. Larry
Jameson. Humana Press Inc. Totowa, New Jersey.
Henco, K., Brosius, J., Fujisawa, A., Fujisawa, J. I., Haynes, J. R., Hochstadt, J.,
Kovacic, T., Pasek, M., Antonelli Schambock, A., Schimd, J., Todokoro,
K., Walchi, M., Nagata, S., & Weissmann, C. (1985). Structural
relationship of human interferon alpha genes and pseudogenes. Journal of
Molecular Biology, 185(2), 227-260.
Jonasch E., and Haluska F.G. (2001). Interferon in oncological practice: review of
interferon biology, clinical application, and toxicities. The Oncologist, 6,
34-55.
Klaus W., Gsella B., Labhardta A.M., Wipfa B., Senn H. (1997). The three-
dimensional high relarutan structure of human interferon α-2a determined
by heteronuclear NMR spectroscopy in larutan. Journal of Molecular
Biology, 274 (4), 661-675.
Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Ecsodi, J., Boll, W.,
Cantell, K., & Weissmann. (1980). Synthesis in E. coli of a polypeptide
with human leukocyte interferon activity. Nature, 284, 316-320.
doi:10.1038/284316a0
Tae-Ok Bae, Ho-Jin Chang, Jung Ho Kim, and Soon Jae Park. (1995).
Purification and Characteization of Recombinant Human Interferon
Alpha 2a Produced from Saccharomyces cerevisiae. J. Biochem. Mol.
Biol., 28 (6), 477-483.
Chawla-Sarkar, M., Lindner, D. J., Liu, Y. F., Williams, B. R., Sen, G. C.,
Silverman, R. H., & Borden, E. C. (2003). Apoptosis and
interferons: Role of interferon-stimulated genes as mediators of
apoptosis. Apoptosis, 8, 237-249.
Grompe M., Johnson W., and Jameson L. (1998). Recombinant DNA and
genetic techniques. In Principles of molecular medicine. Edited
by J. Larry Jameson. Humana Press Inc. Totowa, New Jersey.
Klaus, W., Gsell, B., Labhardt, A. M., Wipf, B., & Senn, H. (1997). The
Three-dimensional High Resolution Structure of Human
Interferon aaa -2a Determined by Heteronuclear NMR
Spectroscopy in Solution. Journal of Molecular Biolology, 274,
661-675.